Robert A. Bradway - 16 Mar 2026 Form 4 Insider Report for AMGEN INC (AMGN)

Role: Chairman, CEO and President, Director
Signature: /s/ Robert A. Bradway
Issuer symbol: AMGN
Transactions as of: 16 Mar 2026
Net transactions value: $0
Form type: 4
Filing time: 18 Mar 2026, 20:28:33 UTC
Previous filing: 06 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Bradway Robert A	Chairman, CEO and President, Director	ONE AMGEN CENTER DRIVE, THOUSAND OAKS	/s/ Robert A. Bradway	16 Mar 2026	0001396482

Transactions Table

Type	Sym	Class	Transaction	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AMGN	Common Stock	Tax liability	-21,294	-4.1%	$366.21^*	501,862	16 Mar 2026	Direct	F1
holding	AMGN	Common Stock					60,060	16 Mar 2026	By GRAT
holding	AMGN	Common Stock					60,060	16 Mar 2026	By Spousal GRAT
holding	AMGN	Common Stock					29,940	16 Mar 2026	By Spouse

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares include 2,696 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Content

These shares include 2,696 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.